Skip to Main Content

Paper Details

LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity.
ACS Med Chem Lett
99
2018
Arginine, Arginine Methyltransferase 5, LLY-283, LLY-284, PRMT5, Protein arginine methyltransferase 5, RNA, arginine, breast cancer, cancer, cancer cells, cancers, dimethylarginine, gastric cancer, glioblastoma, lymphoma, mouse, type II arginine methyltransferase
Author NameAffiliation
Kenneth WeichertLilly Research Laboratories
Cheryl H ArrowsmithUniversity of Toronto
Cheryl H ArrowsmithUniversity of Toronto and Princess Margaret Cancer Centre, College Street
Dalia Barsyte-LovejoyUniversity of Toronto
Ernesto GuccioneInstitute of Molecular and Cell Biology
  • 1 - 5

Datasets

Release 1.2